PillOseltamivir Phosphate
Brands: Tamiflu · Oseltamivir Phosphate
14 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it14 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| A-S Medication Solutions | unknown | 2 | SUPPLYING |
| Oryza Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 1 | SUPPLYING |
| Asclemed USA, Inc. | unknown | 1 | SUPPLYING |
| Proficient Rx LP | unknown | 1 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 1 | SUPPLYING |
| Genentech, Inc. | unknown | 1 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Epic Pharma, LLC | unknown | 1 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 1 | SUPPLYING |
| Alvogen Inc. | unknown | 1 | SUPPLYING |
| Strides Pharma Science Limited | unknown | 1 | SUPPLYING |
| Novadoz Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 15, 2021RECALLRecall (Class II): Oseltamivir Phosphate for Oral Suspension 6 mg/mL* *Each mL contains 6 mg oseltamivir base after constitution. 60 mL (…
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC
- Jan 21, 2021RECALLRecall (Class III): Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, 60 mL (usable volume after constitution), Rx only, Manufactured for…
Failed Impurities/Degradation Specifications; Out-of-specification test results observed for Impurity C at 9 month long-term stability time point. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide